文献速递主动脉疾病

退行性胸主动脉瘤患者胸主动脉腔内修复术前中性粒细胞-淋巴细胞比值与全因死亡率的关联

Association between Preoperative Neutrophil-lymphocyte Ratio and All-cause Mortality in Patients Treated with Thoracic Endovascular Aortic Repair for Degenerative Thoracic Aortic Aneurysm.
PubMed 文献 · Ann Vasc Surg · 2024-09-27

本研究评估了2013年1月至2021年12月在本大学医院接受胸主动脉腔内修复术(TEVAR)治疗退行性胸主动脉瘤的103例患者,术前中性粒细胞-淋巴细胞比值(NLR)预测全因死亡率的能力。随访9年期间32例(31.1%)死亡,多变量分析显示年龄(HR 1.06)、缺血性心脏病(HR 2.13)和NLR(HR 1.36)可预测TEVAR后全因死亡率,NLR预测全因死亡率的最佳截断值为3.48。结论认为术前NLR升高提示退行性胸主动脉瘤TEVAR患者全因死亡率更高,NLR可能作为TEVAR后总体死亡风险分层的生物标志物。

要点

  • 103例退行性胸主动脉瘤TEVAR患者随访9年,32例(31.1%)死亡。
  • 多变量分析显示年龄(HR 1.06)、缺血性心脏病(HR 2.13)和NLR(HR 1.36)预测全因死亡率。
  • NLR预测全因死亡率的最佳截断值为3.48。

核心结论

  • 术前NLR升高提示退行性胸主动脉瘤TEVAR患者全因死亡率更高,NLR可能作为TEVAR后总体死亡风险分层的生物标志物。

研究设计与样本

  • 本研究评估了2013年1月至2021年12月在本大学医院接受TEVAR治疗退行性胸主动脉瘤的患者数据,共纳入103例。
  • 术前NLR通过绝对中性粒细胞计数除以绝对淋巴细胞计数计算。

主要发现

  • 随访9年期间,103例患者中32例(31.1%)死亡。
  • 多变量分析显示年龄(HR 1.06;95%CI 1.00-1.12;P=0.021)预测TEVAR后全因死亡率。
  • 多变量分析显示缺血性心脏病(HR 2.13;95%CI 1.05-4.36;P=0.038)预测TEVAR后全因死亡率。
  • 多变量分析显示NLR(HR 1.36;95%CI 1.08-1.72;P=0.009)预测TEVAR后全因死亡率。
  • 受试者工作特征曲线确定NLR预测全因死亡率的最佳截断值为3.48。

关键数值与推荐

  • NLR预测全因死亡率的最佳截断值为3.48。
  • 年龄的HR为1.06(95%CI 1.00-1.12;P=0.021)。
  • 缺血性心脏病的HR为2.13(95%CI 1.05-4.36;P=0.038)。
  • NLR的HR为1.36(95%CI 1.08-1.72;P=0.009)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The neutrophil-lymphocyte ratio (NLR) has been increasingly recognized as a reliable surrogate marker for predicting mortality in clinical practice. This study determined the predictive ability of NLR for overall mortality after thoracic endovascular aortic repair (TEVAR) for degenerative thoracic aortic aneurysm (TAA). METHODS: Data from patients treated with TEVAR for degenerative TAA at our university hospital from January 2013 to December 2021 were evaluated. The preoperative NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. RESULTS: One hundred-three patients were included in this study. During a 9-year follow-up, 32 patients (31.1%) died. Multivariable analyses showed that age (hazard ratio [HR], 1.06; 95% confidence interval [CI], 1.00-1.12; P = 0.021), ischemic heart disease (HR, 2.13; 95% CI, 1.05-4.36; P = 0.038), and NLR (HR, 1.36; 95% CI, 1.08-1.72; P = 0.009) predicted all-cause mortality after TEVAR. A receiver operating characteristic curve determined the optimal cutoff value of NLR to predict all-cause mortality was 3.48. CONCLUSIONS: An elevated preoperative NLR is indicative of a higher likelihood of all-cause mortality in patients treated with TEVAR for degenerative TAA, suggesting that NLR could serve as a possible biomarker for stratifying patients at risk of overall mortality after TEVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kano M, Nishibe T, Dardik A, et al. Association between Preoperative Neutrophil-lymphocyte Ratio and All-cause Mortality in Patients Treated with Thoracic Endovascular Aortic Repair for Degenerative Thoracic Aortic Aneurysm. Ann Vasc Surg. 2024. PMID: 39341560. doi:10.1016/j.avsg.2024.07.110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。